Sfg Wealth Management, Llc. Merck & Co., Inc. Transaction History

Sfg Wealth Management, Llc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 19, 2024	SELL	$100.18 - $109.02 $400 - $436	-4 Reduced 0.2%	1,970 $214,000
Q3 2023 Oct 19, 2023	BUY	$102.95 - $114.33 $6,794 - $7,545	66 Added 3.46%	1,974 $203,000
Q2 2023 Jul 14, 2023	BUY	$108.61 - $118.38 $207,227 - $225,869	1,908 New	1,908 $220,000
Q4 2022 Jan 31, 2023	BUY	$87.44 - $112.11 $200,762 - $257,404	2,296 New	2,296 $254,000
Q2 2022 Jul 13, 2022	BUY	$83.49 - $94.64 $195,700 - $221,836	2,344 New	2,344 $214,000

3,820

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $251B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Sfg Wealth Management, Llc., based on Form 13F filings with the SEC.

Stay updated on Sfg Wealth Management, Llc. with notifications on news.